390 related articles for article (PubMed ID: 8623229)
1. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
[TBL] [Abstract][Full Text] [Related]
2. Predominant role of local immunosuppressive effect in enhanced efficacy of liposomal FK506 in organ transplantation.
Ko S; Nakajima Y; Kanehiro H; Hisanaga M; Horikawa M; Aomatsu Y; Yagura K; Kin T; Ohyama T; Nishio K; Yamada T; Nakano H
Transplant Proc; 1997; 29(1-2):529-31. PubMed ID: 9123117
[TBL] [Abstract][Full Text] [Related]
3. The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation.
Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Taki J; Aomatsu Y; Kin T; Yagura K; Nakano H
Transplantation; 1995 May; 59(10):1384-8. PubMed ID: 7539553
[TBL] [Abstract][Full Text] [Related]
4. Significance of newly developed liposomal FK 506 in canine liver transplantation.
Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Taki J; Kido K; Aomatsu Y; Ueno M; Kin T
Transplant Proc; 1995 Feb; 27(1):351-3. PubMed ID: 7533406
[No Abstract] [Full Text] [Related]
5. Comparative studies of FK506 and cyclosporine in canine orthotopic hepatic allograft survival.
Yokota K; Takishima T; Sato K; Osakabe T; Nakayama Y; Uchida H; Aso K; Masaki Y; Ohbu M; Okudaira M
Transplant Proc; 1989 Feb; 21(1 Pt 1):1066-8. PubMed ID: 2468209
[No Abstract] [Full Text] [Related]
6. Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice.
Lopes CT; Gallo AP; Palma PV; Cury PM; Bueno V
Transplant Proc; 2008 Apr; 40(3):856-60. PubMed ID: 18455036
[TBL] [Abstract][Full Text] [Related]
7. TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats.
Kumamoto Y; Tamura A; Volk HD; Reinke P; Löhler J; Tullius SG; Utku N
Transpl Immunol; 2006 Nov; 16(3-4):238-44. PubMed ID: 17138060
[TBL] [Abstract][Full Text] [Related]
8. Experimental and clinical experience with the use of tacrolimus (FK506) in kidney transplantation.
Wagner K; Herget S; Heemann U
Clin Nephrol; 1996 May; 45(5):332-5. PubMed ID: 8738666
[TBL] [Abstract][Full Text] [Related]
9. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
[No Abstract] [Full Text] [Related]
10. Correlation between simplified immunocompetence assay and clinical graft states in kidney or liver transplant recipients.
Shinozuka N; Koyama I; Omoto R; Burdick J
Transplant Proc; 1996 Jun; 28(3):1259. PubMed ID: 8658649
[No Abstract] [Full Text] [Related]
11. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
Shi WY; Liu T; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
[TBL] [Abstract][Full Text] [Related]
12. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
[No Abstract] [Full Text] [Related]
13. Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation.
Guo L; Li XK; Enosawa S; Funeshima N; Suzuki S; Kimura H; Sugawara Y; Tezuka K; Makuuchi M
Liver Transpl; 2004 Jun; 10(6):743-7. PubMed ID: 15162468
[TBL] [Abstract][Full Text] [Related]
14. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
15. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.
Hedayat S; Kershner RP; Su G
J Biopharm Stat; 1996 Nov; 6(4):411-24. PubMed ID: 8969977
[TBL] [Abstract][Full Text] [Related]
16. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
17. [The study of FK506 eye drops preventing and treating immune rejection on limbal allograft transplantation].
Chen J; Zhou Q; Zeng J; Xu JT; Zhao SB; Wang YP
Zhonghua Yan Ke Za Zhi; 2003 Sep; 39(9):550-4. PubMed ID: 14766087
[TBL] [Abstract][Full Text] [Related]
18. In vivo immunosuppressive effect of purine nucleoside phosphorylase inhibitor-8-amino-9-benzyl-guanine in canine renal allograft rejection.
Lin CY; Yen CY
Transplant Proc; 1994 Dec; 26(6):3126-7. PubMed ID: 7998091
[No Abstract] [Full Text] [Related]
19. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
[TBL] [Abstract][Full Text] [Related]
20. Administration of tacrolimus in 50 liver transplantation patients.
Ye QF; Ruzig MA; Gong NQ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
